Jonathan  Olefson net worth and biography

Jonathan Olefson Biography and Net Worth

General Counsel of Syneos Health
Oversees the global legal function, including the Legal, Compliance and Corporate Quality teams; and the Assistant Corporate Secretary

Brings extensive expertise in data analytics, Intellectual Property and global markets, as well as a significant understanding of the consulting and healthcare industries

Previously served as the General Counsel and Secretary of Cotiviti Holdings, where he led the development of the company’s Legal, Compliance and Government Relations departments in preparation for its transition from a private equity portfolio company to being publicly traded on the NYSE

Has significant experience in corporate development, mergers and acquisitions, and private equity backed public companies through his tenures with Cotiviti Holdings and Cognizant Technology Solutions, where he served as Vice President and General Counsel and held leadership positions including Chief Intellectual Property Counsel and Lead Attorney for Corporate Development and M&A

Juris Doctor, The George Washington University Law School; Bachelor of Arts in Political Science, Emory University

What is Jonathan Olefson's net worth?

The estimated net worth of Jonathan Olefson is at least $1.09 million as of July 20th, 2022. Mr. Olefson owns 25,292 shares of Syneos Health stock worth more than $1,087,050 as of November 15th. This net worth approximation does not reflect any other assets that Mr. Olefson may own. Additionally, Mr. Olefson receives an annual salary of $526,130.00 as General Counsel at Syneos Health. Learn More about Jonathan Olefson's net worth.

How old is Jonathan Olefson?

Mr. Olefson is currently 47 years old. There are 6 older executives and no younger executives at Syneos Health. The oldest executive at Syneos Health is Ms. Michelle Keefe, CEO & Director, who is 56 years old. Learn More on Jonathan Olefson's age.

What is Jonathan Olefson's salary?

As the General Counsel of Syneos Health, Inc., Mr. Olefson earns $526,130.00 per year. There are 3 executives that earn more than Mr. Olefson. The highest earning executive at Syneos Health is Ms. Michelle Keefe, CEO & Director, who commands a salary of $876,280.00 per year. Learn More on Jonathan Olefson's salary.

How do I contact Jonathan Olefson?

The corporate mailing address for Mr. Olefson and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected]. Learn More on Jonathan Olefson's contact information.

Has Jonathan Olefson been buying or selling shares of Syneos Health?

Jonathan Olefson has not been actively trading shares of Syneos Health during the last ninety days. Most recently, Jonathan Olefson sold 2,215 shares of the business's stock in a transaction on Wednesday, July 20th. The shares were sold at an average price of $75.00, for a transaction totalling $166,125.00. Following the completion of the sale, the general counsel now directly owns 25,292 shares of the company's stock, valued at $1,896,900. Learn More on Jonathan Olefson's trading history.

Who are Syneos Health's active insiders?

Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Jonathan Olefson Insider Trading History at Syneos Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/20/2022Sell2,215$75.00$166,125.0025,292View SEC Filing Icon  
12/23/2021Sell1,889$100.95$190,694.55View SEC Filing Icon  
3/29/2021Sell4,000$77.00$308,000.0024,725View SEC Filing Icon  
1/25/2021Sell5,336$75.68$403,828.4827,214View SEC Filing Icon  
12/17/2018Buy750$41.27$30,952.50View SEC Filing Icon  
See Full Table

Jonathan Olefson Buying and Selling Activity at Syneos Health

This chart shows Jonathan Olefson's buying and selling at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syneos Health Company Overview

Syneos Health logo
Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.
Read More

Today's Range

Now: $42.98
Low: $42.97
High: $42.99

50 Day Range

MA: $42.86
Low: $42.48
High: $42.98

2 Week Range

Now: $42.98
Low: $22.89
High: $52.23

Volume

7,386,200 shs

Average Volume

1,924,736 shs

Market Capitalization

$4.46 billion

P/E Ratio

62.29

Dividend Yield

N/A

Beta

1.58